605186.SH
健麾信息
SSE · Healthcare · Medical - Specialties · CN
CNY 25.60
−2.74%Year over year
Reported trailing growth
- Revenue
- -4.3%
- EBITDA
- —
- EBIT
- -15.8%
- EPS
- +0.3%
- Free cash flow
- +171.2%
- Operating cash flow
- +40.2%
Forward estimates
Based on analyst estimates
- Revenue
- -69.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.3%
- EBITDA
- -25.1%
- EBIT
- -38.0%
- Net income
- -35.7%
- EPS
- -35.3%
- Free cash flow
- +160.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026